Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Efficacy-Program'

Efficacy-Program published presentations and documents on DocSlides.

Optimal Basket Designs for Efficacy Screening with Cherry-Picking
Optimal Basket Designs for Efficacy Screening with Cherry-Picking
by cheryl-pisano
Optimal Basket Designs for Efficacy Screening wit...
Preexposure Prophylaxis
Preexposure Prophylaxis
by lois-ondreau
Preexposure Prophylaxis Translating the Clinical...
The Impact of Role Models on Life Outcomes of People With Disabilities
The Impact of Role Models on Life Outcomes of People With Disabilities
by ellena-manuel
The Impact of Role Models on Life Outcomes of Peo...
Exploring Science Teaching Efficacy of Early Childhood Majors in a Mixed-Reality Virtual Classroom
Exploring Science Teaching Efficacy of Early Childhood Majors in a Mixed-Reality Virtual Classroom
by liane-varnes
Nazan Bautista. Miami University. Presented at th...
Regenerative farming –
Regenerative farming –
by karlyn-bohler
healthy land, healthy profits, healthy people. 6....
LSU Journal Club Efficacy and Safety of
LSU Journal Club Efficacy and Safety of
by trish-goza
Evolocumab. in. Reducing Lipids and Cardiovascul...
Chapter 1: Research and Theory
Chapter 1: Research and Theory
by mitsue-stanley
“Research on motivation and engagement is essen...
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
by tawny-fly
Sinead Delany-Moretlwe. Wits RHI, University of t...
Obesity & Mental Health
Obesity & Mental Health
by stefany-barnette
An Overview. George Steffian, Ph.D., ABPP. Outlin...
Appropriate Use of Psychoactive Medications in LTC
Appropriate Use of Psychoactive Medications in LTC
by tatyana-admore
Recommendations for Clinical and Regulatory Succe...
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
by ellena-manuel
Program Overview . Discussion Outline. DNA Repair...
Treating HIV Infection: HIV/AIDS Treatment
Treating HIV Infection: HIV/AIDS Treatment
by celsa-spraggs
A Dynamic Field. SINGLE Study. Phase 3, Open-Labe...
1 Structure and mandate of FDA
1 Structure and mandate of FDA
by sherrill-nordquist
Leonard Sacks. Office of Medical Policy. CDER, FD...
Efficacy and safety of switching from boosted-protease inhibitors plus
Efficacy and safety of switching from boosted-protease inhibitors plus
by calandra-battersby
emtricitabine. /tenofovir . disoproxil. fumarate...
Carolyn Moneymaker MD,FAAP
Carolyn Moneymaker MD,FAAP
by faustina-dinatale
General Academic Pediatrics . November 6, 2015. V...
The pharmaceutical industry
The pharmaceutical industry
by pasty-toler
March 27th 2014, University of Zurich . Fabienne ...
Case Management Lab 2: Engage and Motivate
Case Management Lab 2: Engage and Motivate
by lindy-dunigan
Case Management Pre-Service Lab 2.0.1. Agenda. Un...
Module 1: INTRODUCTION TO ORAL
Module 1: INTRODUCTION TO ORAL
by pamella-moone
PrEP. Version. : December . 2018. Outline of tra...
Prospects of the Role of Herbal Medicine in Achieving the Millennium Development Goals for Health:
Prospects of the Role of Herbal Medicine in Achieving the Millennium Development Goals for Health:
by kittie-lecroy
Adjei, B., Agyemang, S., and Mensah, C.M.. KWAME ...
Biosimilar Biological Products
Biosimilar Biological Products
by luanne-stotts
2016 . Clinical Investigator . Training Course. S...
PK/PD: an introduction with the case of antimicrobials
PK/PD: an introduction with the case of antimicrobials
by luanne-stotts
P.L. . Toutain. VMAS . symposium/workshop. Uppsal...
HIV 2015-2016: New Agents, New Strategies
HIV 2015-2016: New Agents, New Strategies
by ellena-manuel
Learning Objectives. EARLY VS DEFERRED ART. The C...
Legislative Advocacy: Why OTCs Go Over Parents’ Heads
Legislative Advocacy: Why OTCs Go Over Parents’ Heads
by test
Allison Baxterbeck. Elizabeth Chang. Amy . DiPila...
Video Feedforward Creating Brighter Futures
Video Feedforward Creating Brighter Futures
by debby-jeon
Background. VFF is an intervention . that promote...
More than an insurance mandate
More than an insurance mandate
by luanne-stotts
Factors Influencing Student Utilization . of Stud...
Clinical Pharmacology 2:
Clinical Pharmacology 2:
by myesha-ticknor
Clinical Pharmacology Considerations During Phase...
Efficacy and Safety of Doravirine
Efficacy and Safety of Doravirine
by giovanna-bartolotta
. 100mg. . QD. . vs . Efavirenz . 600mg. . QD...
Biological Products: concepts, naming,
Biological Products: concepts, naming,
by faustina-dinatale
interchangeability,extrapolation. and safety. Dr...
Superior Efficacy of Dolutegravir (DTG) Plus
Superior Efficacy of Dolutegravir (DTG) Plus
by celsa-spraggs
2 Nucleoside Reverse Transcriptase Inhibitors (NR...
Theory Evaluation of Pender’s
Theory Evaluation of Pender’s
by pamella-moone
Health . Promotion Model . (. HPM. ). Nursing 844...
New Strategies to Prevent CV Events After Hospital Discharge
New Strategies to Prevent CV Events After Hospital Discharge
by luanne-stotts
Program Agenda. Crisis and Unmet Needs in Medical...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by cheryl-pisano
Announcements. Thank you attending the ACCP Cardi...
Adhering to Medical Advice
Adhering to Medical Advice
by alexa-scheidler
Quiz Questions. Which of these is LEAST consisten...
Chapter 11 General Issues in Psychotherapy
Chapter 11 General Issues in Psychotherapy
by lois-ondreau
Overview. This is the first chapter in the sectio...
Efficacy and Safety of Low Molecular Weight Heparin compared to Unfractionated Heparin for Chronic
Efficacy and Safety of Low Molecular Weight Heparin compared to Unfractionated Heparin for Chronic
by mitsue-stanley
R. eview and Meta-Analysis.. Dinesh Keerty, MD. T...
Dos and Don’ts for High-Risk Elderly Patients With AF
Dos and Don’ts for High-Risk Elderly Patients With AF
by ellena-manuel
Why Anticoagulate?. Anticoagulate Even in High-Ri...
Efficacy of combination mucosal vaccination and immunotherapy strategies for the treatment of HPV-a
Efficacy of combination mucosal vaccination and immunotherapy strategies for the treatment of HPV-a
by yoshiko-marsland
Jagan Sastry, PhD. Professor, Department of Immun...
Closing the Achievement
Closing the Achievement
by yoshiko-marsland
Gap . What We Can Learn from . Measuring the . Af...
Tobacco agent training 2015 Insect management update
Tobacco agent training 2015 Insect management update
by debby-jeon
Hannah . Burrack. , Jeremy Sloan, and Aurora . To...
GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D
GLP-1 Agonist Clinical Case Challenge: Intensifying Therapy and Improving Management of T2D
by stefany-barnette
Program Goal. Case Presentation: Diane. Case Pres...